Two February 2026 cholesterol headlines show how to judge study design, real outcomes, and official guidance before changing a medicine or screening plan.
FDA’s 2026 GLP-1 crackdown targets compounded or illegally marketed products, not approved brands. Here’s how patients can verify what they’re taking.
Whooping cough stayed elevated in the U.S. in 2025. Here’s what that means for family vaccines, test timing, and why clinics want suspected cases to call first.
A Raw Farm cheddar recall offers a practical lesson for families: match the product, size, and date, then return or discard it without tasting it.
SAMHSA’s 2026 988 funding may show up first as faster answers, more local routing, and stronger follow-up, not instant growth in in-person crisis care.
Medicare’s 2026 physician payment rule may improve care coordination, telehealth, and home visits, but local staffing and practice finances still matter.
Some plans now have to post 2025 prior-authorization data. Here is what patients and clinicians can learn from the new CMS reports, and what they cannot.
Minnesota’s Medicaid funding deferral does not automatically end coverage. The closer short-term risk is provider payment strain, tighter oversight, and access friction.
FDA’s 2026 crackdown on mass-marketed compounded GLP-1s could tighten safety oversight but also shrink cheaper options for people struggling to afford approved drugs.
The 2025-2030 Dietary Guidelines talk a lot about “real food,” but the bigger everyday question is whether healthy choices become easier to afford, find, and fit real life. That is where the Advisory Committee’s health-equity lens may matter most.
The new federal dietary guidelines matter far beyond your kitchen. For most people, the clearest takeaway is to cut back on highly processed foods, sugary drinks, and refined carbs before fixating on the newer, more debated protein and dairy shifts.
After the ByHeart-linked infant botulism outbreak, the FDA says it is tightening recall follow-through, making formula information easier for families to find, and expanding sampling and surveillance. Here is what changed, what parents should watch for, and what is still not fully known.
Federal officials say the ByHeart-linked infant botulism outbreak is over, but all ByHeart Whole Nutrition infant formula remains recalled. Here’s what parents should do now, which symptoms need urgent care, and what is still unknown.
The March 2026 Star Princess outbreak offers a practical lesson for cruise travelers: do not board while sick, report even mild vomiting or diarrhea quickly, and do not assume deep cleaning alone can stop norovirus.
The latest CDC outbreak data point to an active 2025–2026 norovirus season, with an early fall rise and a peak in early February. But the numbers do not show the biggest weekly spikes seen in the historical comparison. Here’s what the data do and do not mean, plus the prevention steps that matter most at home, school, work, and around food.
As of February 2026, CDC estimated that 65.1% of U.S. infants born since April 1, 2025 were already protected against RSV through maternal immunization only or an infant monoclonal antibody, with another 9.1% of parents saying they definitely planned to get the infant product. For most babies, protection comes from one route or the other, not both. ([cdc.gov](https://www.cdc.gov/rsvvaxview/dashboard/index.html))
CDC says adults 75 and older should get one RSV shot, and adults 50 to 74 should get it only if they have certain high-risk conditions, frailty, or nursing home residence. For healthy adults under 75, current guidance usually means you can wait. ([cdc.gov](https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/adults.html))
CDC says an H5 signal in wastewater can be an early warning worth investigating, but it cannot show whether the source is humans, animals, or animal products such as milk. That means a dot on the map does not by itself prove human cases or community spread, and CDC said on April 3, 2026, that current flu surveillance still showed no indicators of unusual influenza activity in people, including avian influenza A(H5). ([cdc.gov](https://www.cdc.gov/nwss/rv/wwd-h5.html))
CDC’s April 3, 2026 H5 update says there are still no signs of unusual flu activity in people. Here is what 71 U.S. cases do and do not mean, and why worker monitoring still matters.
The move to trivalent flu vaccines did not appear to leave Americans unprotected against a major circulating strain. This season’s weaker flu-shot performance looks more tied to drifted viruses, especially H3N2, than to dropping the long-absent B/Yamagata component.
CDC says U.S. flu activity is falling but still elevated as of March 27, 2026. This season has brought unusually high hospitalization burden, high pediatric severity, and weaker-than-usual vaccine performance against a drifted H3N2 strain—yet vaccination and early antiviral treatment still matter right now. ([cdc.gov](https://www.cdc.gov/fluview/surveillance/2026-week-11.html))
CDC’s April 3, 2026 measles update shows higher U.S. case counts, but not a new national vaccine schedule. The practical message for families and schools is simpler: check written MMR records now, understand who may be excluded after an exposure, and move quickly if catch-up vaccination or post-exposure treatment may be needed.
End of content
End of content
